期刊文献+

放射性核素标记胃泌素及其类似物在肿瘤显像和治疗中的研究进展

Development of Gastrin Related Radiopharmaceuticals for Cancer Imaging and Therapy
下载PDF
导出
摘要 胃泌素是一种脑肠肽,在中枢神经系统中可以作为神经递质,在外周组织中尤其是胃肠道可以看作是激素。胃泌素的功能是通过与细胞胆囊收缩素-B/胃泌素受体相互作用实现的。在核医学靶向诊断和治疗中已将胆囊收缩素-B/胃泌素受体作为靶组织来研究。胆囊收缩素-B/胃泌素受体可以在甲状腺髓样癌、小细胞肺癌、卵巢癌和胃肠内分泌肿瘤等胃泌素受体阳性的肿瘤中过度表达。放射性核素标记的胃泌素可以与多种肿瘤组织的胃泌素受体特异性地结合,可诊断和治疗胃泌素受体阳性肿瘤。本文对胃泌素及类似物在肿瘤的显像和治疗的应用进行了综述。 Gastrin is a kind of braingut peptide and present in both central nervous system(CNS) where it plays the roles of neurotransmitter or neuromodulator and in some peripheral tissues,mainly in gastrointestinal tract,where it may be considered as a hormone.Some researches revealed that most of the effects of gastrin were results from the specific interaction with cell Cholecystokinin-B(CCK-B,formerly CCK-B)/gastrin receptors.CCK-B/gastrin receptors have recently found increasing interest as targets for nuclear medicine applications.A high incidence of CCK-B receptors has been found in human samples of medullary thyroid cancer(MTC),small cell lung cancer(SCLC),stromal ovarian cancers,and also in vivo in gastrointestinal neuroendocrine tumors.Radiolabeled gastrin analogues have high specific affinity to receptor in Cholecystokinin-B/gastrin receptors positive tumor.This article reviews about gastrin and its analogues for cancer imaging and therapy.
出处 《同位素》 CAS 2010年第2期122-128,共7页 Journal of Isotopes
基金 核能开发项目
关键词 放射性核素 标记 胃泌素 肿瘤显像和治疗 radionuclide labeling gastrin cancer imaging and therapy
  • 相关文献

参考文献38

  • 1Dickinson CJ,SawadaM,Guo YJ,et al.Specificity of pro-hormone convertase endoproteolysis of progastrin in AtT-20 cells[J].Clin Invest Med,1995,96(1):1 425-1 431.
  • 2Waldum HL.The cellular localization of the cholecystokinin(gastrin receptor) in the stomach[J].Acta Pharmacol Toxicol,2002,91:359-362.
  • 3Berna MJ,Tapia JA,Sancho V,et al.Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential[J].Curr Opin Pharmacol,2007,7(6):583-592.
  • 4Philippe Biagini,Genevieve Monges,Vincent Vua-roqueaux,et al.The human gastrin/cholecystokinin receptors:type band type c expression in colonic tumors and cell lines[J].Life ciences,1997,61(10):1 009-1 018.
  • 5Lindstrom E,Chen D,Norlen P,et al.Control of gastric acid secretion:targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals[J].Anticancer Agents Med Chem,2008,8(2):186-199.
  • 6Kopin AS,Lee YM,McBride EW,et al.Expression cloning and characterization of the canine parietal cell gastrin receptor[J].Proc Natl Acad Sci USA,1992,89:3 605-3 609.
  • 7Miller LJ,Gao F.Structural basis of cholecystokinin receptor binding and regulation[J].Pharmacol Ther,2008,119(1):83-95.
  • 8Behr TM,Jenner N,Radetzky S,et al.Targeting of cholecystokinin-B/gastrin receptors in vivo:preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin[J].Eur J Nucl Med,1998,25:424-430.
  • 9Rorison KA,Yang Zhiyu,Baldwin GS.Affinity of cholecystokinin receptor antagonists for the gastrin-binding Protein[J].European Journal of Pharmacology,2000,388:9-15.
  • 10Rozengurt E,Walsh JH.Gastrin,CCK,signaling,and cancer[J].Annu Rev Physiol,2001,63:49-76.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部